Home | About | Register | Partners | Contact | Disclaimer
Ludlow Capital - Financing & Syndication Specialists




Ludlow BioVentures


Headquartered in Manhattan, Ludlow BioVentures is a full service investment advisory firm which serves the needs of both private and public biotechnology companies. Our simple approach is to provide customized financial solutions for virtually any of our clients needs.

Services

Capital Formation - assist biotechnology companies in the area of capital formation and institutional relations
Investor Relations - assist biotechnology companies in the area of investor communications and relations
Research Coverage - assist biotechnology companies in the area of targeted investor awareness and retail
Reverse Mergers - assist private biotechnology companies in going public
Patent Advisory - assist biotechnology companies in the area of patent filings and process


Ludlow Biotech Index


Ludlow BioVentures manages the Ludlow Biotech Index, which tracks a diverse basket of biotechnology stocks. Our index provides institutional investors a means to track and trade a basket of more riskier small cap biotechnology stocks, with the reduced risk through diversification.

Ludlow BioVentures also serves as a managing portfolio advisor to the Ludlow Biotech Fund, LP.


Current Clients

BioForce Nanosciences, Inc. Cyroport, Inc.

Wall Streets premier biotechnology investor relations firm

-----------
Contact:

Ludlow BioVentures
Phone: (212) 233-2864
Email: biotech@ludlowcapital.com 



Your use of this website is subject to our terms & conditions. © Ludlow Capital, Inc. 2003 - 2008

This website includes statements that may constitute forward-looking statements made pursuant to the safe harbor
provisions of the U.S. Private Securities Litigation Reform Act of 1995. Although the Company believes that the
expectations reflected in such forward-looking statements are based on reasonable assumptions, such statements
are subject to risks and uncertainties that could cause actual results to differ materially from those projected.

 

thomas j latino